Beijing Xindong Lianchuang Biotechnology

Beijing Sinolion Pharmaceutical Technology (Sinolion) is a prominent integrated pharmaceutical R&D service provider and biotechnology firm headquartered in Beijing, China. Established in 2006, the company specializes in the development of high-end generic drugs, innovative small molecules, and improved therapeutic formulations (Class 2 drugs). Sinolion offers a comprehensive suite of contract research organization (CRO) services, including drug discovery, pharmaceutical chemistry, formulation R&D, clinical trial management, and regulatory registration. The company has played a significant role in China's generic drug consistency evaluation program, successfully bringing numerous cardiovascular and metabolic products to market in collaboration with major domestic pharmaceutical groups. Sinolion operates multiple state-of-the-art R&D centers and maintains a growing internal pipeline focused on oncology and chronic diseases.